Venous Thromboembolism
514
59
65
317
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
102 trials with published results (20%)
Research Maturity
317 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
9.3%
48 terminated out of 514 trials
86.8%
+0.3% vs benchmark
26%
132 trials in Phase 3/4
32%
102 of 317 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 317 completed trials
Clinical Trials (514)
DOAC in Chinese Patients With Atrial Fibrillation
Impact of COVID-19 Vaccines on Cerebrovascular Health
Aspiration Thrombectomy Using the Symphony or Prodigy System
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism
Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study)
The Effect of a VTE Prevention Care Bundle in Total Hip Arthroplasty Patients
Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
The Protrieve PROTECTOR Study
Timing of Thromboprophylaxis After Postpartum Hemorrhage
A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)
An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism
Variations in the Hemostatic System Induced by a Standardized Walking Test
Low Molecular Weight hEparin vs. Aspirin Post-partum
VTE Prevention Following Total Hip and Knee Arthroplasty
Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)